Sphingosine-1-phosphate signaling in human submandibular cells

Area of Science:

• Lipid signaling
• Immunology
• Cell biology

Background:

• Sphingosine-1-phosphate (S1P) is a lipid messenger involved in physiological responses and autoimmune diseases.
• Its role in Sjögren's syndrome and salivary gland pathology is not well understood.
• Investigating S1P signaling in salivary glands is crucial for understanding disease mechanisms.

Purpose of the Study:

• To investigate the effects of S1P on normal human submandibular gland cells.
• To elucidate the signaling pathways activated by S1P in these cells.
• To determine the potential role of S1P in Sjögren's syndrome.

Main Methods:

• Primary human submandibular gland cells were treated with S1P.
• Intracellular calcium ([Ca(2+)](i)) levels were measured.
• Expression of S1P receptors, SphK1, SphK2, interleukin-6, and Fas were analyzed.
• Inhibitors (U73122, 2-APB) were used to block specific pathways.

Main Results:

• S1P significantly increased [Ca(2+)](i) in submandibular gland cells.
• This calcium increase was inhibited by U73122 and 2-APB.
• S1P-induced calcium signaling was independent of muscarinic signaling.
• S1P, unlike carbachol, induced the expression of interleukin-6 and Fas.
• S1P receptors (S1P1-3) and SphK1/2 were expressed in these cells.

Conclusions:

• S1P activates calcium signaling and apoptotic pathways in normal human submandibular gland cells.
• These findings suggest S1P signaling contributes to Sjögren's syndrome pathogenesis.
• Targeting S1P pathways may offer therapeutic strategies for Sjögren's syndrome.